To include your compound in the COVID-19 Resource Center, submit it here.
Cancer immunotherapy play Flexus Biosciences Inc. (San Carlos, Calif.) said it has raised $38 million in two rounds of funding. Kleiner Perkins Caufield & Byers incubated the company and
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury